CA 72.4 - Cancer Marker PFH160
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: Next day (11:00)
CA125 - Ovarian Cancer marker PFH161
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
CA125 - Ovarian Cancer marker - Titre PFH162
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
CA15.3 - Breast Cancer marker PFH163
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
CA15.3 - Breast Cancer marker -Titre PFH164
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
CA19.9 - Pancreatic Cancer Marker PFH165
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
CA19.9 - Pancreatic Cancer Marker - Titre PFH166
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Cabbage PFH167
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cadmium PFH168
Includes:
Sample: WB-Na. Heparin (3ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Cadmium PFH169
Includes:
Sample: Urine (25ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Calcitonin PFH170
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Calcium PFH171
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Calcium PFH172
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Calcium - Spot PFH173
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Calcium/Creatinine - Ratio PFH174
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Candida albicans, PFH175
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Carbamazepine (Tegretol) PFH176
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Carcino Embryonic Antigen (CEA) PFH177
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Carcino Embryonic Antigen (CEA) - Titre PFH178
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Cardiolipin IgA Antibody PFH179
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Cardiolipin IgG Antibody PFH180
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Cardiolipin IgM Antibody PFH181
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Carrot PFH182
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Casein PFH183
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cashew nut PFH184
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cat epithelium PFH185
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Catecholamines PFH186
Includes:
Sample: Urine (25 ml)
Methodology: HPLC
Reporting: 3 & 6 (11:00)
CD 10 / CALLA (Prognostic ALL Marker) PFH187
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD103 (Hairy Cell Marker) PFH188
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD117 (Myeloid Cell Marker) PFH189
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD11b (Myeloid Marker) PFH190
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD11c (Hairy Cell / NHL Marker) PFH191
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD123 (Monocytic Macrophage Marker) PFH192
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD13 (Myeloid Cell Marker) PFH193
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD138 (Plasma Cell Marker) PFH194
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD14 (Monocytic Cell? Marker) PFH195
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD15 (Myeloid Cell Marker) PFH196
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD16 (Natural Killer Cells) PFH197
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD19 (Pan B Cell Marker) PFH198
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD1a (Pan T Cell Marker) PFH199
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD2 (Pan T Cell Marker) PFH200
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD20 (Pan B Cell Marker) PFH201
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD22 (Pan B Cell Marker) PFH202
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD23 (CLL Segregation Marker) PFH203
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD25 (Hairy Cell / NHL Marker) PFH204
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD3 (Pan T Cell Marker) PFH205
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD3 Absolute Count PFH206
Includes:
Sample: WB-EDTA (3ml)
Methodology: Flow Cytometry
Reporting: 11:00/19:00
CD3/CD4/CD8 PFH207
Includes:
Sample: WB-EDTA (3ml)
Methodology: Flow Cytometry
Reporting: 11:00/19:00
CD33 (Myeloid Cell Marker) PFH208
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD34 (Precursor Cell Marker) PFH209
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD34 Viable Cells PFH210
Includes:
Sample: WB-EDTA (3ml)
Methodology: Immunophenotyping
Reporting: Next day (11:00)
CD38 (Plasma Cell / Prognostic CLL Marker) PFH211
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD4 (Pan T Cell Marker) PFH212
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD4 Absolute Count PFH213
Includes:
Sample: WB-EDTA (3ml)
Methodology: Flow Cytometry
Reporting: 11:00/19:00
CD42a (Megakaryocytic Cell Marker) PFH214
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD45 / LCA (Leukocyte Common Antigen) PFH215
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD5 (T Cell / B Cell Subset) PFH216
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD55 (PNH Marker) PFH217
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD56 (Natural Killer Cells) PFH218
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD58 (PNH Marker) PFH219
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD59 (PNH Marker) PFH220
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD61 (Megakaryocytic Cell? Marker) PFH221
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD64 (Monocytic Macrophage Marker) PFH222
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD7 (Pan T? Cell / Early Myeloid Cell Marker) PFH223
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD79a (B Lymphoid Cell Marker) PFH224
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
CD8 (Suppressor T Cell Marker) PFH225
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
Celery PFH226
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Centromere AntiBody IgG PFH227
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Ceruloplasmin PFH228
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Cheddar PFH229
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Chicken PFH230
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Chickpea PFH231
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Chikungunya PFH232
Includes:
Sample: Serum (1ml)
Methodology: Immunochromatography
Reporting: 11:00/18:00
Chlamydia IgA Antibodies PFH233
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 3 & 6 (11:00)
Chlamydia IgG PFH234
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Chlamydia IgM PFH235
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Chloride - CSF PFH236
Includes:
Sample: CSF (1ml)
Methodology: ISE Direct
Reporting: 11:00/19:00
Chloride - Serum PFH237
Includes:
Sample: Serum (1ml)
Methodology: ISE Direct
Reporting: 11:00/19:00
Chloride - Urine PFH238
Includes:
Sample: Urine (25ml)
Methodology: ISE Direct
Reporting: 11:00/19:00
Cholesterol - HDL PFH239
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Cholesterol - LDL PFH240
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Cholesterol - Total PFH241
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Cholinesterase PFH242
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Chromium - Serum PFH243
Includes:
Sample: Serum (1ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Chromium - Urine PFH244
Includes:
Sample: Urine (25ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Chromium - Whole Blood PFH245
Includes:
Sample: WB EDTA (3ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Chromogranin - A PFH246
Includes:
Sample: EDTA -Plasma
Methodology: ELISA
Reporting: 2 (11:00)
Chromosome Analysis, Amniotic Fluid PFH247
Includes:
Sample: Amniotic Fluid - Sterile Falcon Tubes (20-30ml)
Methodology: Karyotyping
Reporting: 14 days (11:00)
Chromosome Analysis, Blood PFH248
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: Karyotyping
Reporting: 15 days (11:00)
Chromosome Analysis, Bone Marrow PFH249
Includes:
Sample: Bone Marrow- Na. Heparin (3ml)
Methodology: Karyotyping
Reporting: 12 days (11:00)
Chromosome Analysis, Cord Blood PFH250
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: Karyotyping
Reporting: 14 days (11:00)
Chromosome Analysis, Leukemic Blood PFH251
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: Karyotyping
Reporting: 12 days (11:00)
Chromosome Analysis, Products of conception PFH252
Includes:
Sample: Products of Conception in Sterile Container with Normal Saline
Methodology: Karyotyping
Reporting: 21 days (11:00)
Circulating Immunocomplex (CIC) PFH253
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 3 & 6 (11:00)
Citrate PFH254
Includes:
Sample: Urine (24 Hrs)
Methodology: Spectrophotometry
Reporting: 4 Days
Cladosporium herbarum PFH255
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Clotting Time (CT) PFH256
Includes:
Sample: Local Procedure
Methodology: Capillary method
Reporting: 11:00/19:00
CMV PCR Quantitative PFH257
Includes:
Sample: WB-EDTA (3 ml)
Methodology: Real Time PCR
Reporting: 3 & 6 (18:00)
Cocaine PFH258
Includes:
Sample: Urine (5ml)
Methodology: Lateral Flow Chromotography
Reporting: Next day (11:00)
Cocklebur PFH259
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cockroach PFH260
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cocoa PFH261
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Coconut PFH262
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Codfish PFH263
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Coffee PFH264
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Common Ragweed PFH265
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Complement 3 (C3) PFH266
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Complement 4 (C4) PFH267
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Complete Blood Count (CBC) PFH268
Includes:
Sample: WB-EDTA (3 ml)
Methodology: Cell Counter
Reporting: 11:00/19:00
Complete Urine Analysis (CUE) PFH269
Includes:
Sample: Urine (5ml)
Methodology: Strip/Microscopy
Reporting: 11:00/19:00
Coombs Test - Direct PFH270
Includes:
Sample: WB-EDTA (3 ml)
Methodology: Gel Microtyping
Reporting: 11:00/19:00
Coombs Test - Indirect PFH271
Includes:
Sample: Serum (1ml)
Methodology: Gel Microtyping
Reporting: 11:00/19:00
Copper - Serum PFH272
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Copper - Urine PFH273
Includes:
Sample: Urine (5 ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Corn PFH274
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cortisol Serum (3 to 5 PM) PFH275
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Cortisol Serum (7 to 9 AM) PFH276
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Cortisol Urine? Total PFH277
Includes:
Sample: Urine (5ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Cottonwood PFH278
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cow Dander PFH279
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cow's milk PFH280
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
C-Peptide PFH281
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Crab PFH282
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
C-Reactive Protein (CRP) -Qualitative PFH283
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
C-Reactive Protein (CRP)-Quantitative PFH284
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:01
Creatine Kinase MB (CK-MB) PFH285
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Creatinine PFH286
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Creatinine PFH287
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Creatinine - Spot PFH288
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Creatinine Clearence Test PFH289
Includes:
Sample: Serum (1 ml) & Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Creatinine Kinase (CPK) PFH290
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Cryptococcus Antigen PFH291
Includes:
Sample: Serum (1 ml)
Methodology: Agglutination Method
Reporting: 11:00/18:00
Cucumber PFH292
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Culture and Sensitivity, Urine PFH293
Includes:
Sample: First Morning mid stream Urine sample in sterile? container/boric acid container
Methodology: Culture & Sensitivity (Manual)
Reporting: 3 days (11:00)
Culture and Sensitivity, Urine (12 Drugs) PFH294
Includes:
Sample: First Morning mid stream Urine sample in sterile? container/boric acid container
Methodology: Culture & Sensitivity (Manual)
Reporting: 3 days (11:00)
Culture and Sensitivity, Urine (22 Drugs) PFH295
Includes:
Sample: First Morning mid stream Urine sample in sterile? container/boric acid container
Methodology: Culture & Sensitivity (Manual)
Reporting: 3 days (11:00)
Culture, Aerobic, Blood PFH296
Includes:
Sample: Blood - Na. Heparin (3-5ml)/BHI Broth
Methodology: Culture & Sensitivity (Manual)
Reporting: Interim:48 hrs Final:7 days
Culture, Aerobic, Blood (Pediatric - Rapid) PFH297
Includes:
Sample: Collect 0.5 ml blood in Na. Heparin or BD Pediatric Blood Culture Bottle
Methodology: Rapid Automated Aerobic BACTEC culture and Automated Identification and sensitivity
Reporting: Interim:24 hrs Final:5 days
Culture, Aerobic, Blood, Rapid PFH298
Includes:
Sample: Collect 3-5 ml blood in Na. Heparin or BD Blood Culture Bottle
Methodology: Rapid Automated Aerobic BACTEC culture and Automated Identification and sensitivity
Reporting: Interim:24 hrs Final:5 days
Culture, Aerobic, Body Fluids, Rapid PFH299
Includes:
Sample: Collect 3 ml to 5 ml of body fluids aseptically in Sterile screw capped container.
Methodology: Rapid Automated Aerobic BACTEC culture and Automated Identification and Sensitivity.
Reporting: 2 days (11:00)
Culture, Aerobic, CSF PFH300
Includes:
Sample: 2-5 ml(1 ml min), CSF in Sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity
Reporting: 2 days (11:00)
Culture, Aerobic, Ear Swab PFH301
Includes:
Sample: Ear swab in Sterile screw capped container. Specifiy Left or Right Ear swab.
Methodology: Conventional culture, Automated Identification & Sensitivity
Reporting: 2 days (11:00)
Culture, Aerobic, Eye swab PFH302
Includes:
Sample: Eye swab in Sterile screw capped container. Specifiy Left or Right Eye swab.
Methodology: Conventional culture, Automated Identification & Sensitivity
Reporting: 2 days (11:00)
Culture, Aerobic, Miscellaneous PFH303
Includes:
Sample: Tissue in normal saline, Body effusion aspirates and swabs etc., in sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity
Reporting: 2 days (11:00)
Culture, Aerobic, Nasal Swab PFH304
Includes:
Sample: Nasal Swab in Sterile screw capped container. Specify left or right nasal swab.
Methodology: Conventional culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture, Aerobic, Pus PFH305
Includes:
Sample: Pus or Pus Swab in Sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity, Gram stain.
Reporting: 2 days (11:00)
Culture, Aerobic, Sputum PFH306
Includes:
Sample: 3-5 ml (1 ml min) sputum in sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture, Aerobic, Throat swab PFH307
Includes:
Sample: Throat swab in sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture, Aerobic, Vaginal Swab PFH308
Includes:
Sample: Vaginal swab in sterile screw capped container.
Methodology: Conventional culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture, Aerobic,? OT Swabs PFH309
Includes:
Sample: Swabs in Sterile Container
Methodology: Culture
Reporting: 2 days (11:00)
Culture, Anaerobic , Blood, Rapid PFH310
Includes:
Sample: Collect 5-8ml blood aseptically in special Plus Anaerobic bottle.
Methodology: Rapid Automated Anaerobic Culture and Identification.
Reporting: 7 days (11:00)
Culture, Anaerobic, Body Fluid, Rapid PFH311
Includes:
Sample: Collect 5-8ml body fluid aseptically in special Plus Anaerobic bottle.
Methodology: Rapid Automated Anaerobic Culture and Identification.
Reporting: 7 days (11:00)
Culture, Fungus (Does not include Anti fungal sensitivity) PFH312
Includes:
Sample: Urine / Swab / Pus / Nail / Hair / Sputum / Body Fluids/ CSF / Skin scrappings
Methodology: Culture & Identification
Reporting: Report Interim1:1week, 2week, Final:3rd week
Culture, Fungus, Blood/Body fluids Rapid (Includes Antibiotic sensitivity for Yeast). PFH313
Includes:
Sample: Collect 3-5 ml whole blood/body fluids aseptically in a Myco/F-Lytic bottle.
Methodology: Rapid Automated Fungus culture.
Reporting: Interim:2 days, Final:15 days
Culture, Nocardia (Does not include Antibiotic Sensitivity) PFH314
Includes:
Sample: Submit PUS from discharging sinus/sputum in sterile screw capped container without fixatives OR tissue/biopsy material/swabs in 1 ml sterile normal saline.
Methodology: Conventional Culture
Reporting: Interim:1 week, Final:3 weeks.
Culture, Stool PFH315
Includes:
Sample: Submit 2-5 g ( 1 g min) stool in a sterile screw capped container.
Methodology: Conventional Culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture, Urine PFH316
Includes:
Sample: First Morning mid stream Urine sample in sterile? container/boric acid container
Methodology: Convential culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Culture,Aerobic, Semen PFH317
Includes:
Sample: Semen in sterile screw capped container
Methodology: Conventional culture, Automated Identification & Sensitivity.
Reporting: 2 days (11:00)
Cultured Aerobic Bacteria Identification PFH318
Includes:
Sample: Pure Isolate on appropriate media.
Methodology: Sub culture and Automated Identification
Reporting: 2 days (11:00)
Cultured Aerobic Bacteria Identification and Sensitivity PFH319
Includes:
Sample: Pure Isolate on appropriate media.
Methodology: Sub culture, Automated Identificatin & Sensitivity
Reporting: 2 days (11:00)
Culturue Aerobic Bacteria Sensitivity PFH320
Includes:
Sample: Pure known isolate on appropriate media.
Methodology: Sub culture and Automated Sensitivity
Reporting: 2 days (11:00)
Cyclosporine PFH321
Includes:
Sample: WB-EDTA (3 ml)
Methodology: Chemiluminiscence
Reporting: Next Day (11:00)
CYFRA 21 (Lung Cancer Marker) PFH322
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Cystatin - C PFH323
Includes:
Sample: Serum (1ml)
Methodology: Nephlometry
Reporting: 48 hours
CYSTIC FIBROSIS? (r)F 508/CFTRF508 PFH324
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR
Reporting: 6 Days (11:00)
Cytology -Fluids PFH325
Includes:
Sample: Fluids (3ml)
Methodology: PAP Staining & Microscope
Reporting: Next day (11:00)
Cytology -FNAC PFH326
Includes:
Sample: Air Dried/Fixed Slides
Methodology: H&E Staining & Microscope
Reporting: Next day (11:00)
Cytology -PAP PFH327
Includes:
Sample: Air Dried/Fixed Slides
Methodology: PAP Staining & Microscope
Reporting: Next day (11:00)
Cytomegalovirus DNA PCR - Qualitative PFH328
Includes:
Sample: WB-EDTA (3ml)/CSF (1ml)/Urine (10 ml)
Methodology: Real Time PCR
Reporting: 7 Days (11:00)
Cytomegalovirus IgG Antibody PFH329
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Cytomegalovirus IgG Antibody PFH330
Includes:
Sample: CSF(1ml)
Methodology: ELISA
Reporting: 3 & 6 (11:00)
Cytomegalovirus IgM Antibody PFH331
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Cytomegalovirus IgM Antibody PFH332
Includes:
Sample: CSF(1ml)
Methodology: ELISA
Reporting: 3 & 6 (11:00)
